Position
Fidelity in Alto Neuroscience, Inc.
Back to the book · All holders of ANRO
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $24.7K$22.48 → $26.39
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 6.37K | $113.5K | — | — | — | 0.0% |
| Q1 2026 | 6.31K | $141.9K | $22.48 | $29.5K | −$1.07K | 0.0% |
| Q2 2026 | 6.33K | $166.9K | $26.39 | $24.7K | $290 | 0.0% |